Nc1ccn([C@@H]2O[C@H](C(=O)NCc3ccc4c(c3)OCO4)[C@@H](O)[C@H]2O)c(=O)n1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?